GlassScriptPhysician profile
Jessie V Miller
NPI 1699002337
$920.89
in general payments reported to CMS, 2019-2025
14 companies · $799 in 2025
The $799 reported for 2025 was more than what 76% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $122 · 2025: $799.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $921.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $920.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $217.10 | 2024-2025 | Fintepla, Nayzilam |
| Jazz Pharmaceuticals INC. | $152.28 | 2024-2025 | |
| Neurelis, INC. | $105.72 | 2025 | Valtoco |
| Acadia Pharmaceuticals INC | $73.16 | 2025 | Daybue |
| Otter Pharmaceuticals, LLC | $61.40 | 2025 | Sympazan |
| Azurity Pharmaceuticals, INC. | $57.65 | 2025 | Zonisade |
| Collegium Pharmaceutical, INC. | $55.67 | 2025 | Jornay Pm |
| Tris Pharma INC | $46.12 | 2025 | Onyda Xr |
| Supernus Pharmaceuticals, INC. | $34.78 | 2025 | Qelbree |
| Catalyst Pharmaceuticals, INC. | $30.47 | 2025 | |
| Abbvie INC. | $26.92 | 2025 | |
| Noven Therapeutics, LLC | $24.56 | 2025 | Xelstrym |
| Ironshore Pharmaceuticals INC. | $20.76 | 2024 | |
| Aucta Pharmaceuticals, INC. | $14.30 | 2025 | Motpoly Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessie Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.